Earnings To Watch: Simmons First National (SFNC) Reports Q2 Results Tomorrow
Simmons First National beat analysts' revenue expectations by 3% last quarter, reporting revenues of $216 million, up 7.2% year on year. It was a slower quarter for the company, with a significant miss of analysts' EPS estimates and a miss of analysts' tangible book value per share estimates.
Is Simmons First National a buy or sell going into earnings? Read our full analysis here, it's free.
This quarter, analysts are expecting Simmons First National's revenue to grow 10.1% year on year to $217.1 million, a reversal from the 5.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.39 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Simmons First National has missed Wall Street's revenue estimates five times over the last two years.
Looking at Simmons First National's peers in the banks segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Fulton Financial's revenues decreased 3.2% year on year, beating analysts' expectations by 1.9%, and FB Financial reported a revenue decline of 40.1%, falling short of estimates by 43.5%. FB Financial traded down 4.4% following the results.
Read our full analysis of Fulton Financial's results here and FB Financial's results here.
There has been positive sentiment among investors in the banks segment, with share prices up 8.3% on average over the last month. Simmons First National is up 6.6% during the same time and is heading into earnings with an average analyst price target of $21.60 (compared to the current share price of $19.44).
Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Revenue Beat: Seatrium Limited Beat Analyst Estimates By 22%
As you might know, Seatrium Limited (SGX:5E2) just kicked off its latest half-yearly results with some very strong numbers. Statutory earnings beat expectations, with revenues of S$5.4b coming in a massive 22% ahead of forecasts, while earnings per share (eps) of S$0.042 beat expectations by 5.7%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Taking into account the latest results, the current consensus, from the nine analysts covering Seatrium, is for revenues of S$9.85b in 2025. This implies a small 6.9% reduction in Seatrium's revenue over the past 12 months. Statutory earnings per share are predicted to leap 23% to S$0.096. Before this earnings report, the analysts had been forecasting revenues of S$9.49b and earnings per share (EPS) of S$0.11 in 2025. While next year's revenue estimates increased, there was also a real cut to EPS expectations, suggesting the consensus has a bit of a mixed view of these results. Check out our latest analysis for Seatrium The consensus price target was unchanged at S$2.76, suggesting the business is performing roughly in line with expectations, despite some adjustments to profit and revenue forecasts. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Seatrium, with the most bullish analyst valuing it at S$2.96 and the most bearish at S$2.50 per share. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects. Of course, another way to look at these forecasts is to place them into context against the industry itself. We would highlight that revenue is expected to reverse, with a forecast 13% annualised decline to the end of 2025. That is a notable change from historical growth of 44% over the last five years. By contrast, our data suggests that other companies (with analyst coverage) in the same industry are forecast to see their revenue grow 9.6% annually for the foreseeable future. So although its revenues are forecast to shrink, this cloud does not come with a silver lining - Seatrium is expected to lag the wider industry. The Bottom Line The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. They also upgraded their revenue estimates for next year, even though it is expected to grow slower than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Seatrium going out to 2027, and you can see them free on our platform here. It might also be worth considering whether Seatrium's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
8 minutes ago
- Yahoo
Southern Acids (M) Berhad (KLSE:SAB) Is Paying Out A Dividend Of MYR0.05
The board of Southern Acids (M) Berhad (KLSE:SAB) has announced that it will pay a dividend on the 11th of November, with investors receiving MYR0.05 per share. This payment means the dividend yield will be 1.5%, which is below the average for the industry. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Southern Acids (M) Berhad's Projected Earnings Seem Likely To Cover Future Distributions Even a low dividend yield can be attractive if it is sustained for years on end. However, Southern Acids (M) Berhad's earnings easily cover the dividend. This means that most of what the business earns is being used to help it grow. Over the next year, EPS could expand by 2.8% if recent trends continue. If the dividend continues along recent trends, we estimate the payout ratio will be 18%, which is in the range that makes us comfortable with the sustainability of the dividend. Check out our latest analysis for Southern Acids (M) Berhad Southern Acids (M) Berhad Has A Solid Track Record The company has been paying a dividend for a long time, and it has been quite stable which gives us confidence in the future dividend potential. The last annual payment of MYR0.05 was flat on the annual payment from10 years ago. Dividends have grown relatively slowly, which is not great, but some investors may value the relative consistency of the dividend. Dividend Growth May Be Hard To Achieve Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Earnings have grown at around 2.8% a year for the past five years, which isn't massive but still better than seeing them shrink. Earnings growth is slow, but on the plus side, the dividend payout ratio is low and dividends could grow faster than earnings, if the company decides to increase its payout ratio. Southern Acids (M) Berhad Looks Like A Great Dividend Stock Overall, we like to see the dividend staying consistent, and we think Southern Acids (M) Berhad might even raise payments in the future. The company is easily earning enough to cover its dividend payments and it is great to see that these earnings are being translated into cash flow. All of these factors considered, we think this has solid potential as a dividend stock. It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. Still, investors need to consider a host of other factors, apart from dividend payments, when analysing a company. For instance, we've picked out 1 warning sign for Southern Acids (M) Berhad that investors should take into consideration. Looking for more high-yielding dividend ideas? Try our collection of strong dividend payers. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
RichTech Digital Berhad Full Year 2025 Earnings: EPS: RM0.023 (vs RM0.036 in FY 2024)
RichTech Digital Berhad (KLSE:RTECH) Full Year 2025 Results Key Financial Results Revenue: RM8.25m (up 5.9% from FY 2024). Net income: RM3.57m (down 34% from FY 2024). Profit margin: 43% (down from 69% in FY 2024). The decrease in margin was driven by higher expenses. EPS: RM0.023 (down from RM0.036 in FY 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period RichTech Digital Berhad Earnings Insights Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Diversified Financial industry in Asia. Performance of the market in Malaysia. The company's shares are down 7.5% from a week ago. Risk Analysis You should always think about risks. Case in point, we've spotted 4 warning signs for RichTech Digital Berhad you should be aware of, and 1 of them is potentially serious. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
